Policy / Regulatory

China Drug Administration Implementation Regulations Set for May 2026 Launch

Henlius Triple Combo Gets NMPA Nod for Advanced Solid Tumor Trials
CompanyDrug

Henlius Triple Combo Gets NMPA Nod for Advanced Solid Tumor Trials

Hengrui's HRS-5346 Lp(a) Inhibitor Gets China Breakthrough Therapy Designation in $1.97B Merck Deal
CompanyDrug

Hengrui’s HRS-5346 Lp(a) Inhibitor Gets China Breakthrough Therapy Designation in $1.97B Merck Deal

IVD Medical Launches Nipah Virus Detection Kit with AI Early Warning Platform
CompanyDeals

IVD Medical Launches Nipah Virus Detection Kit with AI Early Warning Platform

Betta Pharmaceuticals' BPI-572270 RAS Inhibitor Gets NMPA Nod for Solid Tumor Trials
CompanyDrug

Betta Pharmaceuticals’ BPI-572270 RAS Inhibitor Gets NMPA Nod for Solid Tumor Trials

Nanjing Leads Biolabs Secures FDA Fast Track for LBL-034 in Multiple Myeloma
CompanyDrug

Nanjing Leads Biolabs Secures FDA Fast Track for LBL-034 in Multiple Myeloma

NMPA Suspends Two Indian Pharma APIs Over GMP Violations
Policy / Regulatory

NMPA Suspends Two Indian Pharma APIs Over GMP Violations

Zhaoke Ophthalmology Expands BRIMOCHOL PF Presbyopia Distribution to Singapore and Vietnam
CompanyDeals

Zhaoke Ophthalmology Expands BRIMOCHOL PF Presbyopia Distribution to Singapore and Vietnam

Innovent Biologics Secures FDA Fast Track for IBI3003 Trispecific Antibody in Multiple Myeloma
CompanyDrug

Innovent Biologics Secures FDA Fast Track for IBI3003 Trispecific Antibody in Multiple Myeloma

Insilico Medicine Partners with Qilu Pharma on AI Drug Development
CompanyDeals

Insilico Medicine Partners with Qilu Pharma on AI Drug Development

Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader
CompanyDeals

Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader

Aucta Pharma Files for Hong Kong IPO with CNS and Rare Disease Pipeline
CompanyDrug

Aucta Pharma Files for Hong Kong IPO with CNS and Rare Disease Pipeline